2024-12-25, Wed.

Top Stories       Business       Culture & Life       Science & Technology       World

Lecture

Notification

 

NEWS > Science & Technology


Boomi Boosts Data Management Capabilities With Acquisition of Modern Data Integration Provider Rivery

Date: 2024-12-24

CONSHOHOCKEN, PA. -- Boomi™, the intelligent integration and automation leader, announced a definitive agreement to acquire Rivery, a modern data integration provider that offers cutting-edge Change Data Capture (CDC) for real-time, efficient data movement. Rivery’s skilled data management team will join Boomi, strengthening the company’s ability to deliver world-class solutions to customers and accelerate its trajectory as a leader in the integration and automation space. The acquisition, expected to close by the end of 2024 pending customary closing conditions, reinforces Boomi’s commitment to delivering a seamless, unified platform for intelligent integration and automation, API management, and data management. Terms of the deal remain undisclosed.

“This acquisition marks an important milestone for Boomi as we expand our platform to address the evolving data management needs of businesses in the age of data-driven decision-making and AI,” said Steve Lucas, Chairman and CEO of Boomi. “Rivery’s differentiated low-code Extract, Load, and Transform (ELT) capabilities and CDC technology align perfectly with our strategy to deliver seamless, powerful tools that transform data into a strategic asset. By integrating Rivery’s solutions and welcoming its exceptional team, we are doubling down on our mission to help organizations thrive in a rapidly changing digital landscape.”

Accelerating Boomi’s Vision to Simplify Data Management

Rapidly increasing data volumes, more data sources, and the complexity of integrating disparate systems are just a few of the challenges organizations face today. Many struggle with data silos, lack of data quality, and insufficient governance. To harness the full potential of trusted AI, and ensure the data accuracy, accessibility, and security needed for data-driven decision-making, companies must implement robust data orchestration and management strategies.

“Low latency requirements are emerging across modern enterprises, and CDC technology is increasingly used to ensure real-time updates and timely data-driven insights, recommendations and actions,” said Doug Henschen, VP and Principal Analyst at Constellation Research. “Rivery’s technologies will not only facilitate seamless integration of data across silos, but also empower businesses to make informed decisions and deploy trusted AI solutions that can adapt to evolving market demands.”

Rivery’s modern data integration platform, paired with its market-leading CDC technology, complements Boomi’s existing capabilities by enabling organizations to build intuitive, end-to-end data pipelines faster and more efficiently. This combination allows customers to quickly deploy data pipelines utilizing ELT capabilities.

“This is a transformative moment for Rivery’s employees, customers, and partners,” said Itamar Ben Hemo, CEO of Rivery. “Our end-to-end platform has established a strong brand in the data management landscape, serving over 450 customers globally and addressing their evolving needs. The unified platform offered by Boomi merges critical elements essential for every company today: API management, integration and automation, and data management—all supported by strong AI foundations.”



 to the Top List of News

Novotech Named a Fierce CRO Award Winner in the Excellence
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
The Next Gen of AI Awaits, GIGABYTE Sets the Benchmark for HPC at CES 2025
SpaceRISE Signs Concession Contract to Deliver Europe¡¯s IRIS©÷ Connectivity Network
Boomi Boosts Data Management Capabilities With Acquisition of Modern Data Integration Provider Rivery
Korean Robotaxi Startup Sonnet.AI Secures Level 4 Autonomous Shuttles Certification
KIOXIA NVMe SSD Cryptographic Module Achieves FIPS 140-3 Level 2 Validation

 

CHMP Recommends Approval of Galderma¡¯s Nemolizumab for Moderate-to-Se...
BrightPath Bio and Cellistic Announced Process Development and Manufac...
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engi...
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Tria...
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Th...
Abu Dhabi¡¯s Technology Innovation Institute Inaugurates Open-Source A...
DNP Achieves Fine Pattern Resolution on EUV Lithography Photomasks for...
Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
Kioxia Develops OCTRAM (Oxide-Semiconductor Channel Transistor DRAM) T...
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance...

 

 

60, Gamasanro 27gil, Guro-gu, Seoul, Korea, e-mail: news@newsji.com

Copyright, NEWSJI NETWORK.